SCHEMBL9998161

SCHEMBL9998161

CC(=O)OCC(=Cc1ccc(C(C)(C)C)cc1)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 3/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 1/20 0.38
TRPV1 Q8NER1 2/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
HTT P42858 1/20 0.37
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
EPHX2 P34913 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997678 0.83 ACHE (0.38) TRPV1MEN1KMT2AHTTNR1H4
SCHEMBL25161985 0.83 CYP1A2 (0.45) CYP1A2SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL9997587 0.83 CYP1A2 (0.45) CYP1A2SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL9998404 0.83 LMNA (0.42) CYP1A2SMN1; SMN2LMNAMAPTMEN1
SCHEMBL9997585 0.83 CYP1A2 (0.45) CYP1A2SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL9998344 0.82 LMNA (0.49) CYP1A2LMNAMAPTMEN1KMT2A
SCHEMBL9997578 0.82 KMT2A (0.49) CYP1A2SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL9998226 0.82 CYP2C9 (0.43) SMN1; SMN2ALDH1A1HPGDL3MBTL1
SCHEMBL9998250 0.82 KDM4E (0.42) SMN1; SMN2ALDH1A1LMNAMAPTHPGD
SCHEMBL9998202 0.81 MEN1 (0.47) SMN1; SMN2ALDH1A1MAPTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP1A2 19/4885SMN1; SMN2 3151/4885ALDH1A1 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.